Abu Shara Shamsur Rouf

Abu Shara Shamsur Rouf

Auto-generated profile, based on publicly available information

Abu Shara Shamsur Rouf

Department of Pharmaceutical Technology, University of Dhaka, Dhaka, Bangladesh

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2021 in Main Group Chemistry
Verified
Journal Article
Closed access
PDF file
SEShafia Farhana Etu
Shafia Farhana Etu
MHMD ALAMGIR HOSSAIN
MD ALAMGIR HOSSAIN
ARAbu Shara Shamsur Rouf
Abu Shara Shamsur Rouf
AAAli Alqahtani
Ali Alqahtani
NQNazmul Qais
Nazmul Qais
Cancer is accountable for the demise of numerous lives worldwide annually. In this research a derivative of lumichrome, 5,10-dihydro-7,8-dimethyl alloxazine was assessed for its anticancer property through docking study. It was appraised after performing molecular docking study of the 5,10-dihydro-7,8-dimethyl alloxazine, there was a strong interaction between multiple oncogenic target proteins like CDK2/CCNE2 (–8.5 kcal/mol), TDP2 (–8 kcal/mol), NAD-SIRT2 (–10.9 kcal/mol) and lung cancer and acute lymphoblastic leukemia (ALL). Additionally, according to ADMET analysis, the synthesized compound 5,10-dihydro-7,8-dimethyl alloxazine also has good physicochemical characteristics to be a drug candidate. Consequently, these verdicts will assist the development of a novel anti-lung cancer and anti-leukemic agent which will eventually improve the endurance of cancer patients.

25 May 2022 in Malaysian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
SJSadia Jahan
Sadia Jahan
MAMd Mahbubul Alam
Md Mahbubul Alam
MD Samiul IslamMD Samiul Islam
MD Samiul Islam
DLDilshad Noor Lira
Dilshad Noor Lira
ARAbu Shara Shamsur Rouf
Abu Shara Shamsur Rouf
The intent of the research work was to develop and validate a simple, selective and precise reversed phase ultra-high performance liquid chromatography (RP-UHPLC) method for the determination of ledipasvir. A forced degradation study was performed as per International Conference on Harmonisation (ICH) guidelines Q1A (R2) and Q1B. Ledipasvir was found to be well separated from degradation products using an analytical C18 column (150 mm × 4.6 mm i.d., 5 μm particle size) with a ratio of mobile phase (75:25 v/v) consisting of methanol and 0.1% trifluoroacetic acid (TFA) kept at ambient temperature. The average retention time of ledipasvir was found 4.45 min at 254 nm wavelength with 1.6 mL/min isocratic flow rate and 10 µL injection volume. Linearity, accuracy, precision, sensitivity, robustness, and ruggedness were studied according to ICH guideline Q2 (R1) to validate the method. Then, this validated method was applied for forced degradation studies of ledipasvir. In conclusion, the developed method has been successfully used to study degradation behaviour of ledipasvir and may be useful to quantify the drug in different pharmaceutical dosage forms.